Skip to main content
logo
Aspen Pharmacare Holdings Limited (JSE:APN)
South Africa flag South Africa · Delayed Price · Currency is ZAR · Price in ZAc
13,140
+340 (2.66%)
Mar 31, 2026, 5:00 PM SAST

Revenue by Segment

Millions ZAR. Fiscal year is Jul - Jun.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Jun '25 Jun '24 Jun '23 Jun '22 Jun '21 Jun '20 Jun '19 Jun '18 Jun '17 Jun '16
Commercial Pharmaceuticals - Prescription
12.52B11.38B10.29B--
Commercial Pharmaceuticals - Prescription Growth
10.01%10.64%---
Commercial Pharmaceuticals - OTC
9.81B9.71B9.39B--
Commercial Pharmaceuticals - OTC Growth
1.09%3.39%---
Commercial Pharmaceuticals - Injectables
9.89B9.48B10.80B--
Commercial Pharmaceuticals - Injectables Growth
4.23%-12.15%---
Manufacturing
11.15B14.14B12.19B10.95B9.89B
Manufacturing Growth
-21.14%15.96%11.34%10.68%35.64%
Commercial Pharmaceuticals - Sterile Focus Brands
---10.25B10.69B
Commercial Pharmaceuticals - Sterile Focus Brands Growth
----4.10%11.19%
Commercial Pharmaceuticals - Regional Brands
---17.41B17.18B
Commercial Pharmaceuticals - Regional Brands Growth
---1.29%2.58%
Total
43.36B44.71B42.66B38.61B37.77B
Total Growth
-3.00%4.80%10.50%2.22%12.20%

Revenue by Geography

Millions ZAR. Fiscal year is Jul - Jun.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Jun '25 Jun '24 Jun '23 Jun '22 Jun '21 Jun '20 Jun '19 Jun '18 Jun '17 Jun '16
Europe CIS
14.68B17.60B14.64B13.11B13.50B
Europe CIS Growth
-16.59%20.26%11.69%-2.93%16.85%
Africa Middle East
10.57B9.51B8.80B10.28B9.65B
Africa Middle East Growth
11.15%8.03%-14.36%6.53%6.54%
Americas
6.84B6.71B5.10B4.30B4.01B
Americas Growth
1.97%31.64%18.70%7.21%0.28%
Asia
4.96B4.20B5.62B5.23B5.19B
Asia Growth
18.10%-25.27%7.50%0.65%17.11%
Australasia
6.31B6.69B6.55B5.70B5.42B
Australasia Growth
-5.59%2.00%14.92%5.20%17.26%
Total
43.36B44.71B40.71B38.61B37.77B
Total Growth
-3.00%9.82%5.45%2.22%12.20%
Source: S&P Global Market Intelligence.